𝗪𝗲𝗲𝗸𝗹𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 #13 📢

Improved therapeutic outcomes through better dose design

A centric approach to dose design is critical in enhancing patient outcomes and experiences while reducing medical spending and boosting pharmaceutical sales. Despite the prominence of large-molecule biologic therapies, small-molecule drugs remain prevalent, highlighting the continued significance of solid dosage forms in drug delivery.

Pharmaceutical companies acknowledge the importance of patient-centric design, stressing the importance of early patient-focused input in development stages to optimize drug substance and product design decisions. Investing in dose design that incorporates patients' needs and concerns can prevent substantial post-approval study costs, leading to more effective therapies.

Addressing adherence and polypharmacy issues through user-friendly dosage forms will continue to drive advancements in dose design, ultimately delivering more effective and economically viable healthcare solutions.

🛈 Article by: Manufacturing Chemist
🛈 Source: Manufacturing Chemist (2017)